ASP Isotopes (ASPI) Status Update summary
Event summary combining transcript, slides, and related documents.
Status Update summary
23 Nov, 2025Recent achievements and operational updates
Shipped first samples of enriched silicon-28 to a U.S. customer, with commercial production beginning in March 2025.
Ytterbium-176 enrichment reached 92.4% in intermediate product; first final product batch expected by end of August 2025, with semi-continuous production delayed to late Q3 or early Q4 2025.
Signed a major MOU with Fermi for a joint venture to produce nuclear fuels and enrich strategic isotopes at a Texas energy complex.
Listed on the Johannesburg Stock Exchange, with trading commencing August 27, 2025, strengthening ties with South African stakeholders.
Carbon-12 and Carbon-14 projects progressing, with Carbon-14 procurement now managed internally and first commercial Carbon-12 product expected in September 2025.
Strategic partnerships and synergies
Merger with Renergen aims to create a vertically and horizontally integrated critical materials business, combining helium and isotopic materials for semiconductors and rocketry.
Collaboration with Quantum Leap Energy to develop energy isotopes and leverage expertise in fluorination and scale-up technologies.
U.S. government engagement includes discussions for grants and loans, with Renergen already securing a $500 million loan for helium supply critical to U.S. national security.
Plans to spin out Quantum Leap Enrichment as a standalone public company in 2H 2025, pending approvals.
Anticipates closing the Renergen acquisition in Q3 2025, subject to regulatory and third-party consents.
Market and product development
Focus on producing isotopes such as HALU, Lithium-6, Lithium-7, silicon-28, and strategic gases for semiconductors at the Fermi site.
South African helium is considered strategic due to high concentration, strong U.S.-South Africa relations, and advantageous shipping logistics.
Natural gas from Renergen provides a low-cost energy source, supporting competitive production costs for isotope enrichment.
Demand for Carbon-12 exceeds Carbon-14, prompting assessment of facility expansion to supply both.
Received permits for laser equipment to enrich Nickel-64, Gadolinium-160, and Zinc-68, accelerating facility construction plans.
Latest events from ASP Isotopes
- Helium and isotope production ramp up amid global shortages, with major commercialization by 2026.ASPI
2nd Annual CG Virtual Sustainability Summit12 Mar 2026 - Expansion in isotopes, new contracts, and regulatory progress set up strong 2024 growth.ASPI
Emerging Growth Virtual Conference25 Feb 2026 - Pursuing global leadership in isotope supply with advanced enrichment tech and strategic expansion.ASPI
Corporate presentation4 Feb 2026 - Ytterbium-176 enrichment achieved; strong cash, plant ramp-up, and growth in isotope demand.ASPI
Q4 20244 Feb 2026 - Expanding isotope production, securing major contracts, and advancing HALEU for nuclear energy.ASPI
Emerging Growth Conference7711 Jan 2026 - Isotope enrichment firm seeks up to $100M in flexible offerings, with $25M at-the-market via Canaccord.ASPI
Registration Filing16 Dec 2025 - Shareholders will vote on director elections, a new equity plan, and auditor ratification at the 2024 meeting.ASPI
Proxy Filing2 Dec 2025 - Annual meeting to elect directors, ratify auditor, and highlight governance and compensation.ASPI
Proxy Filing25 Nov 2025 - Q3 2025 delivered strong revenue growth, major contracts, and strategic expansion moves.ASPI
Q3 202521 Nov 2025